Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)
China flag China · Delayed Price · Currency is CNY
47.54
+0.10 (0.21%)
At close: Feb 6, 2026

SHE:300957 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
5,1535,7075,7074,9984,0082,621
Other Revenue
29.1129.1120.5516.1214.6315.91
5,1825,7365,7275,0144,0222,636
Revenue Growth (YoY)
-17.92%0.15%14.23%24.65%52.57%35.64%
Cost of Revenue
1,3991,5651,4621,262977.08635.17
Gross Profit
3,7834,1704,2663,7523,0452,001
Selling, General & Admin
3,1953,3793,0232,3911,9261,276
Research & Development
266.86295.17298.82254.7113.2263.44
Other Operating Expenses
127.4763.0647.4554.7152.1210.77
Operating Expenses
3,5913,7503,3822,7002,0971,355
Operating Income
192.04420.76883.61,052948.45645.86
Interest Expense
-16.66-17.59-4.97-4.75-4.19-1.33
Interest & Investment Income
105.0682.592.91100.8833.625.7
Currency Exchange Gain (Loss)
-1.23-1.23-0.720.03-0-
Other Non Operating Income (Expenses)
4.63-1.13-215.84-1.72-0.53-2.21
EBT Excluding Unusual Items
283.84483.32754.971,147977.35648.01
Impairment of Goodwill
-90.69-90.69----
Gain (Loss) on Sale of Investments
174.31177.55-17.24-5.5210.8-
Gain (Loss) on Sale of Assets
-0.6-4.150.69-0.030.52-0.17
Asset Writedown
10-25----
Other Unusual Items
101.6367.37130.3972.7529.21-
Pretax Income
478.49608.4868.821,2141,018647.84
Income Tax Expense
112.27113.61109.61163.33153.81104.08
Earnings From Continuing Operations
366.23494.79759.211,051864.06543.75
Minority Interest in Earnings
-6.068.26-2.420.8-1.14-0.25
Net Income
360.16503.05756.81,051862.92543.51
Net Income to Common
360.16503.05756.81,051862.92543.51
Net Income Growth
-39.20%-33.53%-28.02%21.83%58.77%31.94%
Shares Outstanding (Basic)
424419423424407360
Shares Outstanding (Diluted)
424419423424407360
Shares Change (YoY)
0.66%-0.85%-0.27%4.15%13.09%-0.39%
EPS (Basic)
0.851.201.792.482.121.51
EPS (Diluted)
0.851.201.792.482.121.51
EPS Growth
-39.60%-32.96%-27.82%16.98%40.40%32.46%
Free Cash Flow
568.66316.48336.16416.02882.04341.57
Free Cash Flow Per Share
1.340.760.800.982.170.95
Dividend Per Share
0.6000.6000.6000.8000.6000.450
Dividend Growth
-0.08%-0.08%-24.94%33.33%33.33%60.71%
Gross Margin
73.00%72.71%74.48%74.83%75.71%75.91%
Operating Margin
3.71%7.34%15.43%20.99%23.58%24.50%
Profit Margin
6.95%8.77%13.21%20.97%21.45%20.61%
Free Cash Flow Margin
10.97%5.52%5.87%8.30%21.93%12.96%
EBITDA
305.81516.08954.321,110968.11659.61
EBITDA Margin
5.90%9.00%16.66%22.15%24.07%25.02%
D&A For EBITDA
113.7795.3270.7258.2319.6613.74
EBIT
192.04420.76883.61,052948.45645.86
EBIT Margin
3.71%7.34%15.43%20.99%23.58%24.50%
Effective Tax Rate
23.46%18.67%12.62%13.46%15.11%16.07%
Revenue as Reported
5,1825,7365,5225,0144,0222,636
Advertising Expenses
-2,0461,9221,5341,249811.84
Source: S&P Global Market Intelligence. Standard template. Financial Sources.